[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:miller-dieker-syndrome":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":71,"states":72},"Miller-Dieker Syndrome",10,[7,15,22,28,35,42,48,53,59,65],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04061421","Active Myeloid Target Compound Combinations in MDS\u002FMPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:14.396999Z","2026-05-05T02:43:27.663703Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT04187703","5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies",[19],"Early Phase 1","2026-08-26T02:19:29.922117Z","2026-05-05T02:43:27.320206Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT07071155","Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes\u002FMyeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia",[19],"2026-08-26T02:15:27.567165Z","2026-05-05T02:43:29.411655Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":33,"content_modified":34},"NCT06502145","Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome",[32],"Phase 1","2026-08-26T02:18:51.009190Z","2026-05-05T02:43:28.852980Z",{"nct_id":36,"title":37,"phases":38,"status":12,"updated_at":40,"content_modified":41},"NCT05365035","A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts",[39],"Phase 2","2026-08-26T02:16:21.385056Z","2026-05-05T02:43:27.978920Z",{"nct_id":43,"title":44,"phases":45,"status":12,"updated_at":46,"content_modified":47},"NCT07044544","Trial of Novel Anti-leukemia Agents in Flu\u002FMel RIC Transplant for Myeloid Malignancies",[32],"2026-08-26T02:15:21.365312Z","2026-05-05T02:43:27.317386Z",{"nct_id":49,"title":50,"phases":51,"status":12,"updated_at":40,"content_modified":52},"NCT05732103","A Study of CTX-712 in Relapsed\u002FRefractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes",[11],"2026-05-05T02:43:27.279350Z",{"nct_id":54,"title":55,"phases":56,"status":12,"updated_at":57,"content_modified":58},"NCT03471260","Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies",[11],"2026-08-26T02:15:20.225313Z","2026-05-05T02:43:27.087679Z",{"nct_id":60,"title":61,"phases":62,"status":12,"updated_at":63,"content_modified":64},"NCT07362225","MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)",[],"2026-08-26T02:15:36.077529Z","2026-05-13T02:55:06.699757Z",{"nct_id":66,"title":67,"phases":68,"status":12,"updated_at":69,"content_modified":70},"NCT07143669","Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations",[],"2026-08-26T02:16:28.221034Z","2026-05-13T02:55:06.669934Z",[],[73,77,80,84],{"state":74,"count":75,"slug":76},"New York",4,"new-york",{"state":78,"count":75,"slug":79},"Texas","texas",{"state":81,"count":82,"slug":83},"Florida",3,"florida",{"state":85,"count":82,"slug":86},"Illinois","illinois"]